Kommissionen fastsætter efter proceduren i artikel 21, hvilke tekniske foranstaltninger der er nødvendige for at løse eventuelle vanskeligheder i forbindelse med anvendelsen af dette direktivs bestemmelser på navnlig inerte emballagematerialer, der findes i meget små mængder (dvs. ca. 0,1 vægtprocent) på fællesskabsmarkedet, primæremballager til medicinske anordninger og lægemidler, små emballager og luksusemballager."
The Commission, in accordance with the procedure referred to in Article 21, shall determine the technical measures necessary to deal with any difficulties encountered in applying the provisions of this Directive in particular to inert packaging materials, put on the market in very small quantities (i.e. approximately 0,1 % by weight) in the European Union, primary packaging for medical devices and pharmaceutical products, small packaging and luxury packaging."